Financial Performance - For the quarter ended December 2024, Tandem Diabetes Care, Inc. reported revenue of $252.45 million, reflecting a 28.3% increase year-over-year [1] - The earnings per share (EPS) was reported at -$0.44, compared to -$0.27 in the same quarter last year, indicating a decline [1] - The reported revenue was slightly below the Zacks Consensus Estimate of $255.18 million, resulting in a revenue surprise of -1.07% [1] - The company experienced an EPS surprise of -76.00%, with the consensus EPS estimate being -$0.25 [1] Key Metrics - Shares of Tandem Diabetes Care have returned -8.4% over the past month, while the Zacks S&P 500 composite changed by -2.3% [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3] Geographic Sales - United States sales reached $214.56 million, exceeding the average estimate of $190.90 million by three analysts, representing a year-over-year increase of 42.2% [4] - Sales outside the United States were reported at $68.09 million, significantly surpassing the average estimate of $59.87 million, with a year-over-year change of 148291.5% [4] - Pump sales in the United States totaled $98.44 million, slightly below the average estimate of $101.47 million, marking a 19.5% year-over-year increase [4] - Supplies and other sales in the United States were $85.92 million, compared to the average estimate of $89.43 million, reflecting a 6% year-over-year change [4] - Pump sales outside the United States were $25.77 million, exceeding the average estimate of $19.85 million, with a year-over-year increase of 47.2% [4] - Supplies and other sales outside the United States reached $42.32 million, surpassing the average estimate of $40.50 million, indicating a 14.9% year-over-year change [4] - Total revenue from supplies and other was $128.24 million, slightly below the average estimate of $128.87 million [4] - Revenue from pumps was reported at $124.21 million, exceeding the average estimate of $121.53 million [4]
Here's What Key Metrics Tell Us About Tandem Diabetes Care (TNDM) Q4 Earnings